Form 4: Haemonetics Corp Executive Reports Stock Transactions

Laurie A. Miller, SVP of Human Resources at Haemonetics Corp, reports the acquisition and disposal of company stock and stock options.

Summary

• On May 17, 2024, Laurie A. Miller, SVP of Human Resources at Haemonetics Corp, reported transactions involving the company's stock.
• 76 shares were disposed of to cover tax obligations related to vesting restricted stock units at a price of $95.73 per share.
• Miller also acquired 2,089 shares in the form of restricted stock units (RSUs) under the company's 2019 Long-Term Incentive Compensation Plan.
• These RSUs vest in three equal annual installments starting on the first anniversary of the grant date.
• Each RSU represents the right to receive one share of Haemonetics common stock when vested.
• Additionally, Miller acquired 4,591 non-qualified stock options with an exercise price of $95.73, vesting in annual increments of 25% beginning on the first anniversary of the grant date.
• Following these transactions, Miller beneficially owns 16,173 shares of common stock and 4,591 derivative securities.

Sentiment

Score: 5

Explanation: Neutral sentiment as the filing reflects routine stock transactions related to executive compensation.

Positives

• The acquisition of 2,089 shares in the form of RSUs indicates a long-term incentive for the executive.
• The acquisition of 4,591 non-qualified stock options further aligns the executive's interests with the company's performance.

Future Outlook

The RSUs vest in three equal annual installments beginning on the first anniversary of the grant date, and the options vest in annual increments of 25% beginning on the first anniversary of the grant date.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's confidence in the company's prospects.

Comparison to Industry Standards

• Executive compensation packages often include a mix of salary, stock options, and restricted stock units to align management's interests with those of shareholders.
• The vesting schedules for RSUs and stock options are typical, designed to incentivize long-term performance.
• Companies like Medtronic and Boston Scientific also use similar compensation structures for their executives.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders.
• The filing provides transparency to shareholders regarding executive compensation.

Key Dates